Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Etoposide | 0.01 | uM | 5 | 156.25 | 28.48 | 77.00 | 95.00 | 0.8105 | 0.7723 |
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 5 | 156.25 | 28.48 | 68.00 | 95.00 | 0.7158 | 0.6500 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 5 | 156.25 | 28.48 | 91.00 | 95.00 | 0.9579 | 0.9511 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 5 | 156.25 | 28.48 | 134.00 | 95.00 | 1.4105 | 1.4377 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 5 | 156.25 | 28.48 | 133.00 | 95.00 | 1.4000 | 1.4272 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 5 | 156.25 | 28.48 | 114.00 | 95.00 | 1.2000 | 1.2212 |
| SK-BR-3 | PLX-4720 | 10 | uM | 5 | 156.25 | 28.48 | 81.00 | 95.00 | 0.8526 | 0.8247 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 5 | 156.25 | 28.48 | 102.00 | 95.00 | 1.0737 | 1.0835 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 5 | 156.25 | 28.48 | 772.00 | 95.00 | 8.1263 | 5.6766 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 5 | 156.25 | 28.48 | 110.00 | 95.00 | 1.1579 | 1.1760 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 5 | 156.25 | 28.48 | 77.00 | 95.00 | 0.8105 | 0.7723 |
| SK-BR-3 | PLX-4720 | 1 | uM | 5 | 156.25 | 28.48 | 75.00 | 95.00 | 0.7895 | 0.7457 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 5 | 156.25 | 28.48 | 83.00 | 95.00 | 0.8737 | 0.8505 |
| SK-BR-3 | Nilotinib | 10 | uM | 5 | 156.25 | 28.48 | 662.00 | 95.00 | 6.9684 | 5.1114 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 5 | 156.25 | 28.48 | 101.00 | 95.00 | 1.0632 | 1.0717 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 5 | 156.25 | 28.48 | 79.00 | 95.00 | 0.8316 | 0.7986 |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 66.00 | 95.00 | 0.6947 | 0.6219 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 81.00 | 95.00 | 0.8526 | 0.8247 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 40.00 | 95.00 | 0.4211 | 0.2159 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 102.00 | 95.00 | 1.0737 | 1.0835 | |
| SK-BR-3 | Etoposide | 1 | uM | 5 | 156.25 | 28.48 | 73.00 | 95.00 | 0.7684 | 0.7187 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 5 | 156.25 | 28.48 | 93.00 | 95.00 | 0.9790 | 0.9757 |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 149.00 | 95.00 | 1.5684 | 1.5912 | |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 5 | 156.25 | 28.48 | 51.00 | 95.00 | 0.5368 | 0.3983 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 5 | 156.25 | 28.48 | 145.00 | 95.00 | 1.5263 | 1.5509 |